Analyst Upgrades – NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL) Stock Gets Upgraded By KeyCorp from Equal Weight ➝ Overweight to

ME Staff
-
0

Analyst Ratings For NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL)

Today, NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL) stock received an upgrade by KeyCorp from Equal Weight ➝ Overweight with a price target of $115.85 ➝ $130.00.

Some recent analyst ratings include

  • 6/15/2018-KeyCorp Upgrade from a “Equal Weight ➝ Overweight” rating to a “” rating.
  • 4/20/2018-Mitsubishi UFJ Financial Group initiated coverage with a Neutral rating.
  • 3/14/2018-Morgan Stanley Reiterated Rating of Equal Weight ➝ Equal Weight.
  • 2/16/2018-Barclays Reiterated Rating of Hold.
  • 2/15/2018-Credit Suisse Group Reiterated Rating of Hold.
  • 2/14/2018-SunTrust Banks Upgrade from a “Hold ➝ Buy” rating to a “” rating.

Recent Insider Trading Activity For NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL)
NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL) has insider ownership of 2.10% and institutional ownership of 97.20%.

  • On 5/14/2018 George Massaro, Director, sold 1,218 with an average share price of $107.19 per share and the total transaction amounting to $130,557.42.
  • On 5/1/2018 David Ross Smith, Insider, sold 945 with an average share price of $104.23 per share and the total transaction amounting to $98,497.35.
  • On 3/9/2018 George M Milne Jr, Director, sold 7,740 with an average share price of $115.00 per share and the total transaction amounting to $890,100.00.
  • On 3/6/2018 Birgit Girshick, Insider, sold 9,893 with an average share price of $109.10 per share and the total transaction amounting to $1,079,326.30.
  • On 3/6/2018 James C Foster, CEO, sold 24,008 with an average share price of $110.00 per share and the total transaction amounting to $2,640,880.00.
  • On 2/28/2018 David Ross Smith, CFO, sold 100 with an average share price of $108.43 per share and the total transaction amounting to $10,843.00.
  • On 2/28/2018 James C Foster, CEO, sold 3,372 with an average share price of $107.39 per share and the total transaction amounting to $362,119.08.

Recent Trading Activity for NYSE:CRL – Charles River Laboratories Intl. (NYSE:CRL)
Shares of NYSE:CRL – Charles River Laboratories Intl. closed the previous trading session at 116.02 up +1.55 1.35% with 116.26000213623047 shares trading hands.